Novocure (NASDAQ:NVCR) has launched MyLink, a new tool that allows patients to download their Optune usage data from the comfort of home.
Novocure initiated a phased launch with an initial
wave of 30 U.S. patients to be followed by a broad rollout to all
patients in the coming months.
Optune is a noninvasive, antimitotic cancer treatment for glioblastoma multiforme.
https://seekingalpha.com/news/3579479-novocure-launches-mylink-tool-in-u-s
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.